China Biologic Products Holdings Overview

China Biologic Products Holdings Cost of Revenue

Cost of Revenue analysis for CBPO.

Quarterly Cost of Revenue

$37.53M

↓ 1.67% YoY

As of Dec 31, 2020

Annual Cost of Revenue (TTM)

$179.94M

↑ 3.02% YoY

Trailing 12 months ending Dec 31, 2020

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin